• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

Introduction to p-Methylbenzylidene-p-butylaniline (CAS No. 38549-81-4)

p-Methylbenzylidene-p-butylaniline, with the chemical formula C₁₉H₂₁N, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This molecule, identified by its CAS number 38549-81-4, has garnered attention due to its structural uniqueness and potential applications in various chemical synthesis processes. The presence of both aromatic and aliphatic groups in its molecular structure makes it a versatile intermediate in the development of more complex chemical entities.

The synthesis of p-Methylbenzylidene-p-butylaniline typically involves condensation reactions between appropriately substituted benzaldehyde derivatives and butylaniline. The introduction of the methyl group at the para position of the benzylidene component enhances its reactivity, making it a valuable building block in the construction of more intricate molecular frameworks. This compound's ability to participate in various organic transformations, such as Michael additions and cross-coupling reactions, underscores its importance in synthetic chemistry.

In recent years, researchers have been exploring the applications of p-Methylbenzylidene-p-butylaniline in the development of novel pharmaceuticals. Its structural features suggest potential utility as an intermediate in the synthesis of bioactive molecules targeting neurological disorders. For instance, studies have indicated that derivatives of this compound may exhibit properties relevant to the modulation of neurotransmitter systems, which could be exploited in the treatment of conditions such as depression and anxiety.

The compound's role in material science is also emerging as a promising area of investigation. Its ability to form stable complexes with metal ions has led to experiments exploring its use as a ligand in catalytic systems. These complexes have shown promise in facilitating various organic transformations under mild conditions, highlighting the compound's potential as a catalyst or co-catalyst in industrial processes.

Advances in computational chemistry have further enhanced our understanding of p-Methylbenzylidene-p-butylaniline. Molecular modeling studies have provided insights into its electronic structure and reactivity, enabling researchers to predict and design more efficient synthetic routes. These computational approaches have also been instrumental in identifying new derivatives with tailored properties for specific applications.

The pharmacological profile of p-Methylbenzylidene-p-butylaniline continues to be a subject of intense research. Preclinical studies have begun to unravel its potential effects on biological pathways, particularly those involving enzymes and receptors critical for neural function. The compound's interaction with these targets may offer a foundation for developing new therapeutic strategies that address unmet medical needs.

Safety considerations are paramount when handling p-Methylbenzylidene-p-butylaniline. While it is not classified as a hazardous substance under standard regulatory frameworks, appropriate laboratory practices must be followed to ensure safe handling. This includes using personal protective equipment (PPE) such as gloves and safety goggles, working in well-ventilated areas, and adhering to established protocols for chemical storage and disposal.

The future prospects for p-Methylbenzylidene-p-butylaniline are bright, with ongoing research poised to unlock new applications across multiple domains. As our understanding of its properties grows, so too does the potential for innovation in pharmaceuticals, materials science, and beyond. The continued exploration of this compound promises to yield valuable insights and advancements that could benefit society in numerous ways.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)